Skip to main content
. 2024 Oct 30;24:1222. doi: 10.1186/s12879-024-10122-8

Table 3.

Evaluation of descriptive features according to treatment

Invasive Treatment p
Splenectomy
(n = 5; %31.3)
PCD
(n = 11; %68.7)
n (%) n (%)
Age (year) Median (Min-Max) 39 (22–52) 63 (23–78) a0,008**
Sex Female 3 (60,0) 2 (18,2) b0,245
Male 2 (40,0) 9 (81,8)
HVD No 4 (80,0) 7 (63,6) b1,000
Yes 1 (20,0) 4 (36,4)
DM No 5 (100) 6 (54,5) b0,119
Yes 0 (0) 5 (45,5)
Pain No 2 (40,0) 3 (27,3) b1,000
Yes 3 (60,0) 8 (72,7)
Fever No 3 (60,0) 6 (54,5) b1,000
Yes 2 (40,0) 5 (45,5)
ICU ( n  = 15) No 5 (100) 8 (80,0) b0,524
Yes 0 (0) 2 (20,0)
Mortality No 5 (100) 8 (72,7) b0,509
Yes 0 (0) 3 (27,3)
Abscess Size (cm) Median (Min-Max) 6,25 (2,7–15) 9,5 (4,5–15,5) a0,327
Length of stay (Day) Median (Min-Max) 12 (4–32) 17 (3–53) a0,461

aMann Whitney U Test bFisher’s Exact Test **p < 0,01

PCD: Percutaneous Catheter Drainage, HVD: Heart Valve Disease, DM: Diabetes Mellitus, ICU: Intensive Care Unit